Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07561411Recruiting
Randomised trial of ropivacaine in chronic pain (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Incidence of chronic pain at 3 months. Started May 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07561411.